Holen Sie sich die Stockscreener-App
7.74
5.38%
-0.44
Handel nachbörslich:
7.74
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Lifecore Biomedical, ... - Bluefield Daily Telegraph
Notice to Long-Term Shareholders of Cytokinetics, Inc. - GlobeNewswire
Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR) - Seeking Alpha
Important Notice to Long-Term Shareholders of CarMax, Inc. - GlobeNewswire
Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement - TMX Newsfile
KeyBanc maintains Sector Weight rating on Lifecore Biomedical stock By Investing.com - Investing.com UK
LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit - GuruFocus
(LFCR) Volatility Zones as Tactical Triggers - Stock Traders Daily
EBIT per share of Lifecore Biomedical, Inc. – DUS:LDE - TradingView — Track All Markets
HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Lifecore Biomedical, Inc.(NasdaqGS: LFCR) added to NASDAQ Biotechnology Index - marketscreener.com
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc. stock overvalued by current metricsJuly 2025 Spike Watch & Technical Pattern Recognition Alerts - Улправда
Is Lifecore Biomedical Inc. stock positioned for long term growthJuly 2025 Sector Moves & Community Verified Watchlist Alerts - Улправда
How sustainable is Lifecore Biomedical Inc. stock dividend payout2025 Historical Comparison & Fast Moving Trade Plans - Улправда
One Lifecore Biomedical Insider Raised Their Stake In The Previous Year - Yahoo Finance
Can Lifecore Biomedical Inc. stock maintain operating marginsMarket Performance Recap & AI Enhanced Trade Execution Alerts - Улправда
Support Test: Is Lifecore Biomedical Inc. stock vulnerable to regulatory risksWeekly Trend Report & AI Based Buy/Sell Signal Reports - Улправда
Can Lifecore Biomedical Inc. (LDE) stock deliver strong annual returnsEarnings Overview Report & Daily Stock Trend Watchlist - ulpravda.ru
Can Lifecore Biomedical Inc. stock maintain growth trajectoryCEO Change & Real-Time Buy Signal Alerts - DonanımHaber
Is Lifecore Biomedical Inc. stock dividend yield sustainableJuly 2025 Short Interest & Trade Opportunity Analysis Reports - DonanımHaber
Can Lifecore Biomedical Inc. stock resist sector downturnsDollar Strength & Verified High Yield Trade Plans - DonanımHaber
How institutional buying supports Lifecore Biomedical Inc. stockTreasury Yields & AI Forecast for Swing Trade Picks - Bölüm Sonu Canavarı
Investment Report: Is Lifecore Biomedical Inc. stock overvalued by current metricsQuarterly Performance Summary & AI Powered Market Entry Strategies - Улправда
Lifecore Biomedical to Join Nasdaq Biotech Index - marketscreener.com
Lifecore Biomedical to be Added to Nasdaq Biotech Index - The Manila Times
Is Lifecore Biomedical Inc. stock vulnerable to regulatory risksJuly 2025 WrapUp & Consistent Return Investment Signals - Улправда
Lifecore signs CDMO agreement with global pharma company By Investing.com - Investing.com Nigeria
Entry Recap: Why Lifecore Biomedical Inc. stock is favored by top institutionsWeekly Trade Report & Weekly Momentum Picks - moha.gov.vn
Lifecore Biomedical, Inc. Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer - marketscreener.com
Lifecore signs CDMO agreement with global pharma company - Investing.com India
Lifecore Biomedical Signs Agreement for Injectable Pharmaceutical Development Services with Major Global Partner - Quiver Quantitative
Lifecore Biomedical Signs CDMO Master Services Agreement with New Large Multinational Pharmaceutical Customer - Sahm
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect - ACCESS Newswire
Keybanc Initiates Coverage of Lifecore Biomedical (LFCR) with Sector Weight Recommendation - MSN
Lifecore Biomedical to Participate at 44th Annual J.P. Morgan Healthcare Conference - marketscreener.com
Understanding the Setup: (LFCR) and Scalable Risk - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire
What analysts say about Lifecore Biomedical Inc LDE stockFederal Reserve Announcements & Outperform the Market with Aggressive Picks - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Is Lifecore Biomedical Inc a good long term investmentMarket Sentiment Report & High Yield Stock Picks - earlytimes.in
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal
Will Lifecore Biomedical Inc. (LDE) stock see insider accumulationWeekly Risk Report & Community Consensus Trade Signals - Newser
Will Lifecore Biomedical Inc. (LDE) stock attract long term capital inflowsWall Street Watch & Accurate Entry/Exit Alerts - Newser
The Technical Signals Behind (LFCR) That Institutions Follow - news.stocktradersdaily.com
Will Lifecore Biomedical Inc. (LDE) stock split increase liquidityMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
Will Lifecore Biomedical Inc. (LDE) stock benefit from sector leadership - Newser
Will Lifecore Biomedical Inc. (LDE) stock keep raising dividendsBreakout Watch & Daily Stock Trend Watchlist - Newser
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - ACCESS Newswire
2.19%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):